AM Potential in Tissue Engineering to Drive Amniotic Membrane Market’s Growth

1
AM Potential in Tissue Engineering to Drive
Amniotic Membrane Markets Growth
Triton Market Research presents the Global
Amniotic Membrane Market report sectioned by
End-users (Specialized Clinics, Hospitals,
Ambulatory Surgical Wounds, Research Centers
Laboratories), Application (Ophthalmology,
Surgical Wounds, Other Applications), Type
(Lyophilization Amniotic Membrane, Cryopreserved
Amniotic Membrane), and by Geography (Latin
America, Asia-Pacific, Europe, North America,
Middle East and Africa). The report also
discusses the Market Summary, Industry Outlook,
Impact of COVID-19, Key Insights, Porters Five
Forces Analysis, Market Attractiveness Index,
Vendor Scorecard, Key Market Strategies, Drivers,
Challenges, Opportunities, Competitive Landscape,
Research Methodology Scope, Global Market Size,
Forecasts Analysis (2022-2028). Based on
Tritons research report, the global amniotic
membrane market is expected to grow at a CAGR of
7.01 during the forecast period 2022-2028.
Request Free Sample Report https//www.tritonmark
etresearch.com/reports/amniotic-membrane-marketre
quest-free-sample The amniotic membrane refers
to the innermost layer of the fetal placenta. It
is used for various treatments, including ocular
surface repair and tissue transplantation.
2
Amniotic membrane or amnion has shown potential
to be used as a scaffold in numerous tissue
engineering applications. In this regard, the
genipin-crosslinked group (clAM) of human
amniotic membranes has better biostability and
biocompatibility. Therefore, the application of
amnion in tissue engineering creates novel growth
opportunities for the amniotic membrane market
globally. On the contrary, the use of an amniotic
membrane is limited as its use in treating lung
and other organ damages is still under research.
Hence, the limited use of amnion restricts the
amniotic membrane markets global growth. The
Asia-Pacific region is anticipated to witness the
fastest growth over the forecast period. The
regions robust growth is mainly owing to the
growing applications of amnion across China,
India, and South Korea. In China, the rising
number of accidents and cosmetic surgery trends
have increased the application of AM for various
treatments. The demand for eye surgeries to
prevent glasses is another reason supporting
amniotic membrane use in eye treatments.
Therefore, as stated above, all these factors
drive the amniotic membrane market on a
progressive path across the region. The notable
companies in the amniotic membrane market include
Sky Biologics LLC, Human Regenerative
Technologies, Labtician Ophthalmics Inc, Amino
Technology LLC, Surgenix LLC, Organogenesis,
MiMedx, Amniox Medical Inc, Celularity Inc,
Integra Lifescience Corp, Bio Tissue Inc, Smith
and Nephew Plc, Surgilogix LLC, and Katena
Products Inc. The market is heavily fragmented
however, it is expected to witness significant
development over the forecast period. The barrier
of entry is high as players require high capital
investment in research, clinical trials, and
more. Hence, the threat of new players is low.
Further, since the market is emerging with no
product differentiation, innovation and research
are expected to drive the competition among
existing players. This indicates the competition
levels to be moderate over the forecast
period. Contact Us sales_at_tritonmarketresearch.
com Phone [phone]